On Friday, Opko Health Inc (NASDAQ: OPK) was -1.59% drop from the session before settling in for the closing price of $1.26. A 52-week range for OPK has been $1.19 – $2.04.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 1.59% annually for the last half of the decade. When this article was written, the company’s average yearly earnings per share was at -326.79%. With a float of $358.23 million, this company’s outstanding shares have now reached $671.61 million.
In an organization with 2997 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 32.12%, operating margin of -21.43%, and the pretax margin is -0.08%.
Opko Health Inc (OPK) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Opko Health Inc stocks. The insider ownership of Opko Health Inc is 54.83%, while institutional ownership is 27.24%. The most recent insider transaction that took place on Apr 10 ’25, was worth 169,712. In this transaction CEO & Chairman of this company bought 125,000 shares at a rate of $1.36, taking the stock ownership to the 214,001,448 shares. Before that another transaction happened on Apr 08 ’25, when Company’s CEO & Chairman bought 125,000 for $1.48, making the entire transaction worth $184,650. This insider now owns 213,876,448 shares in total.
Opko Health Inc (OPK) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.09 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -326.79% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -11.20% during the next five years compared to 32.04% growth over the previous five years of trading.
Opko Health Inc (NASDAQ: OPK) Trading Performance Indicators
You can see what Opko Health Inc (OPK) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 2.28. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.43.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.08, a number that is poised to hit -0.11 in the next quarter and is forecasted to reach -0.20 in one year’s time.
Technical Analysis of Opko Health Inc (OPK)
Let’s dig in a bit further. During the last 5-days, its volume was 5.04 million. That was better than the volume of 4.48 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 10.84%. Additionally, its Average True Range was 0.07.
During the past 100 days, Opko Health Inc’s (OPK) raw stochastic average was set at 3.64%, which indicates a significant decrease from 8.82% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 40.96% in the past 14 days, which was lower than the 41.79% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.5884, while its 200-day Moving Average is $1.5485. However, in the short run, Opko Health Inc’s stock first resistance to watch stands at $1.2766. Second resistance stands at $1.3132. The third major resistance level sits at $1.3465. If the price goes on to break the first support level at $1.2067, it is likely to go to the next support level at $1.1734. The third support level lies at $1.1368 if the price breaches the second support level.
Opko Health Inc (NASDAQ: OPK) Key Stats
There are 793,053K outstanding shares of the company, which has a market capitalization of 983.38 million. As of now, sales total 713,140 K while income totals -53,220 K. Its latest quarter income was 149,950 K while its last quarter net income were -67,610 K.
